<DOC>
	<DOC>NCT00889356</DOC>
	<brief_summary>The purpose of this study is to determine the Efficacy, Tolerability &amp; Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients with Mixed-Type Vaginosis compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream.</brief_summary>
	<brief_title>Evaluate Efficacy, Tolerability &amp; Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis, Bacterial</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Mixedtype vaginosis Bacterial vaginosis Candidiasis Pregnancy Vaginal bleeding History of recurrent vaginosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>